OBEZİTE VE KRONİK VENÖZ YETMEZLİK
Synopsis
Obesity and chronic venous insufficiency (CVI) are two widespread global health issues that significantly impair quality of life and elevate healthcare costs. Obesity increases intra-abdominal pressure, leading to venous valve insufficiency, enlarged vein diameter, and venous stasis. Furthermore, it promotes chronic inflammation and protrombotic adipokine imbalance, elevating the risk of venous thromboembolism (VTE) and triggering secondary CVI. Patients with obesity frequently exhibit advanced CVI manifestations—such as edema, hyperpigmentation, lipodermatosclerosis, and recalcitrant venous ulcers—even in the absence of severe valvular reflux. Diagnostic delays often occur due to physical examination challenges and symptom-sign discrepancies. Management prioritizes patient education on weight control, mobilization, and leg elevation. Compression therapy remains foundational, though patient compliance can be compromised in obesity. Venoactive agents alleviate symptoms, while endovascular or surgical interventions are utilized when indicated. Weight loss, particularly following bariatric surgery, substantially improves venous hemodynamics and CVI symptoms. Early diagnosis, active treatment, and a multidisciplinary strategy are essential to break the bidirectional negative interaction between obesity and CVI.
References
Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2014;130:333-346.
Özdemir ÖÇ, Altındağ E, Avcı F, Uysal MF. Chronic venous insufficiency. Turkiye Klinikleri J Health Sci. 2016;1(2):125-38.
Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J. Intern. Med. 2019, 34, 269–283.
Labropoulos N, Delis K, Nicolaides AN, et al. The role of the distribution and anatomic extent of reflux in the development of signs and symptoms in chronic venous insufficiency. J Vasc Surg. 1996;23:504-10.
Moore HM, Lane TR, Thapar A, et al. The European burden of primary varicose veins. Phlebology. 2013; 28(Suppl 1): 141–147.
Evans C, Fowkes F, Ruckley C, et al. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health. 1999;53(3):149-53.
Robertson LA, Evans CJ, Lee AJ, et al. Incidence and risk factors for venous reflux in the general population: Edinburgh Vein Study. Eur J Vasc Endovasc Surg. 2014; 48: 208–214.
Lee AJ, Robertson LA, Boghossian SM, et al. Progression of varicose veins and chronic venous insufficiency in the general population in the Edinburgh Vein Study. J Vasc Surg Venous Lymphat Disord. 2015;3(1):18–26 (Epub 2015/01/01).
Jawien A. The influence of environmental factors in chronic venous insufficiency. Angiology. 2003; 54 (Suppl 1) : S19-31.
Köksal C, Alsalehi S, Kocamaz Ö, Sunar H. Treatment of chronic venous insufficiency. Koşuyolu Heart J. 2010; 13:28–33.
Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology. 2008;23(3):103–11 (Epub 2008/05/10).
Scott TE, LaMorte WW, Gorin DR, et al. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg. 1995;22:622-628.
Fowkes FGR, Lee AJ, Evans CJ, et al. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study. Int J Epidemiol. 2001;30:846-852.
Fowkes FGR, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology. 2001;52 (Suppl. 1):S5–15.
Criqui MH, Denenberg JO, Bergan J, et al. Risk factors for chronic venous disease: the San Diego Population Study. J Vasc Surg. 2007;46:331–7.
Clark A, Harvey I, Fowkes FGR. Epidemiology and risk factors for varicose veins among older people: crosssectional population study in the UK. Phlebology. 2010; 25:236–40.
Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Hum Genet. 2010;127:669–74.
Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the post-thrombotic syndrome. Arch Intern Med. 2004;164:17–26.
Danielsson G, Eklof B, Grandinetti A, et al. The influence of obesity on chronic venous disease. Vasc Endovasc Surg. 2002;36:271–6.
Sisto T, Reunanen A, Laurikka J, et al. Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey. Eur J Surg. 1995;161:405–14.
Vlajinac HD, Radak DJ, Marinkovic JM, et al. Risk factors for chronic venous disease. Phlebology. 2012;27:416-22.
Onida S, Davies AH. Predicted burden of venous disease. Phlebology. 2016;31(1 Suppl):74–9 (Epub 2016 /02 /27).
Pappas PJ, Lakhanpal S, Nguyen KQ, et al. The Center for Vein Restoration Study on presenting symptoms, treatment modalities, and outcomes in Medicare-eligible patients with chronic venous disorders. J Vasc Surg Venous Lymphat Disord. 2018;6(1):13–24 (Epub 2017/12/19).
Kahn SR, M’lan CE, Lamping DL, et al. VEINES Study Group. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: results from an international cohort study. J Vasc Surg. 2004; 39: 823–828.
Rabe E, Pannier F. Societal costs of chronic venous disease in CEAP C4, C5, C6 disease. Phlebology. 2010;25 Suppl 1:64–7.
Soydan E, Yılmaz E, Baydur H. Effect of socio-demographic characteristics and clinical findings on the quality of life of patients with chronic venous insufficiency. Vascular. 2017, Vol. 25(4) 382–389.
WHO. Global status report on noncommunicable diseases 2010. Geneva: WHO, 2011.
Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med. 2012; 42: 563–570.
T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. Türkiye Obezite ile Mücadele ve Kontrol Programı (2010-2014). Sağlık Bakanlığı Yayınları, No. 773, Kuban Matbaası, Ankara 2010.
Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9(1):13-27.
Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in United States. JAMA. 1999;282:1539-8.
NIH clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: summary of evidence-based recommendations. Available from: URL:http://www.nhlbi.nih.gov/guidelines/obesity/sum_rec.htm. Accessed Mar 22, 2002.
Gloviczki P, Bergan JJ, Rhodes JM, et al. the North American Study Group. Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: lessons learned from the North American Subfascial Endoscopic Perforator Surgery Registry. J Vasc Surg. 1999;29:489-502.
Davies HO, Popplewell M, Singhal R, et al. Obesity and lower limb venous disease—the epidemic of phlebesity. Phlebology. 2017;32(4):227-233.
Beaglehole R, Salmond CE, Prior IAM. Varicose veins in New Zealand: prevalence and severity. N Z Med J. 1976; 84: 396–99.
Abramson JH, Hopp C, Epstein LM. The epidemiology of varicose veins–a survey of Western Jerusalem. J Epidemiol Community Health. 1981; 35: 213–17.
Brand FN, Dannenberg AL, Abbott RD, et al. The epidemiology of varicose veins: the Framingham study. Am J Prev Med. 1988; 4: 96–101.
Seidell JC, Bakx KC, Deurenberg P, et al. Overweight and chronic illness–a retrospective cohort study, with a follow-up of 6–17 years, in men and women of initially 20–50 years of age. J Chron Dis. 1986; 39: 585–93.
Kurz X, Kahn SR, Abenhaim L et al. Chronic venous disorders of the leg: epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force. Venous Insuffıciency Epidemiologic and Economic Studies. Int Angiol. 1999; 18: 83–102.
Jawien A, Grzela T, Ochwat A: Prevalence of chronic venous insufficiency in men and women in Poland: multicenter cross-sectional study in 40095 patients. Phlebology. 2003;18:110-2.
Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973; 48: 839–46.
Widmer LK. Peripheral venous disorders, Basel III. Bern: Hans Huber, 1978.
Laurikka JO, Sisto T, Tarkka MR, et al. Risk indicators for varicose veins in forty- to sixty-year-olds in the Tampere varicose veins study. World J Surg. 2002; 26: 648–51.
Callam MJ. Epidemiology of varicose veins. Br J Surg. 1994; 81: 167–73.
Chiesa R, Marone EM, Limoni C, et al. Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease. J Vasc Surg. 2007;46:322-30.
Vlajinac HD, Marinkovic JM, Maksimovic MZ, et al. Body mass index and primary chronic venous disease – a cross-sectional study. Eur J Vasc Endovasc Surg. 2013; 45: 293–298.
Musil D, Kaletova M, Herman J. Age, body mass index and severity of primary chronic venous disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:367-71.
Kostas TI, Ioannou CV, Drygiannakis I, et al. Chronic venous disease progression and modification of predisposing factors. J Vasc Surg. 2010;51(4):900-907
Vlajinac H, Marinkovic J, Maksimovic M, et al. Factors Related To Venous Ulceration: A Cross-Sectional Study. Angiology. 2014, Vol. 65(9) 824-830.
Padberg F Jr, Cerveira JJ, Lal BK, et al. Does severe venous insufficiency have a different etiology in the morbidly obese? Is it venous? J Vasc Surg. 2003; 37:79-85.4.
Seidel AC, Belczak CEQ, Campos MB, et al. The impact of obesity on venous insufficiency. Phlebology. 2015, Vol. 30(7) 475–480.
Engelberger RP, Indermühle A, Baumann F, et al. Diurnal changes of lower leg volume in obese and non-obese subjects. International Journal of Obesity. (2014) 38, 801–805.
Sugarman HJ, Sugarman EL, Wolfe L, et al. Risks and benefits of gastric bypass morbidly obese patients with severe venous stasis disease. Ann Surg. 2001:234:41-6.
Benigni JP, Cazaubon M, Tourneroche A, et al. Is obesity an aggravating factor in chronic venous disease? Results of a French epidemiological study in male patients. Int Angiol. 2006;25:297-303.
Mahapatra S, Ramakrishna P, Gupta B, et al. Correlation of obesity & comorbid conditions with chronic venous insufficiency: Results of a single-centre study. Indian J Med Res. 2018 May;147(5):471-476.
vanRij AM, De Alwis CS, Jiang P, et al. Obesity and impaired venous function Eur J Vase Endo vasc Surg. 2008;35:739-44.
Westling A, Boström A, Gustavsson S, et al. Lower limb deep venous incompetence is rare in patients undergoing obesity surgery. Phlebology. 15:30-32, 2000.
Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182-9.
Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. J Intern Med. 2015;277:573–584.
Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020 Apr; 93(2): 162–168.
Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118:978-80.
Ageno W, Piantanida E, Dentali F, et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost. 2003; 89: 305–309.
Karathanos CH, Sfyroeras G, Drakou A, et al. Superficial vein thrombosis in patients with varicose veins: role of thrombophilia factors, age and body mass. Eur J Vasc Endovasc Surg. 2012;43:355-58.
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3–14.
Borch KH, Braekkan SK, Mathiesen EB, et al. Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study. Arterioscler Thromb Vasc Biol. 2010;30:121–127.
Göstl K, Obermayer A, Hirschl M. Pathogenesis of chronic venous insufficiency by obesity. Phlebologie. 2009;38:108-13.
Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism. Front Pediatr. 2018;6:142.
Horvei LD, Grimnes G, Hindberg K, et al. C‐reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost. 2016;14:1561–1571.
Darvall KAL, Sam RC, Silverman SH, et al. Obesity and thrombosis. Eur J Vasc Endovasc Surg 2007;33: 223-33.
Mohr DN, Silverstein MD, Heit JA, et al. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population based study. Mayo Clin Proc. 2000;75:1249-56.
Arfvidsson B, Eklof B, Balfour J. Iliofemoral venous pressure correlates with intraabdominal pressure in morbidly obese patients. Vasc Endovasc Surg. 2005; 39: 505–509.
Sugerman H, Windsor A, Bessos M, et al. Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. J Int Med. 1997; 241: 71–79.
Keiler J, Seidel R, Wree A. The femoral vein diameter and its correlation with sex, age and body mass index – An anatomical parameter with clinical relevance. Phlebology. 2019, Vol. 34(1) 58–69.
Willenberg T, Schumacher A, Amann-Vesti B, et al. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg. 2010;52:664-68.
Willenberg T, Clemens R, Haegeli LM, et al. The influence of abdominal pressure on lower extremity venous pressure and hemodynamics: A human in-vivo model simulating the effect of abdominal obesity. Eur J Vasc Endovasc Surg. 2011; 41: 849–855.
Sobolewskı AP, Deshmukh RM, Brunson BL, et al. Venous hemodynamic changes during laparoscopic cholecystectomy. J Laparoendosc Surg. 1995; 5(6):363-369.
Wiewiora M, Piecuch J, Glück M, et al. Impact of weight loss due to sleeve gastrectomy on shear stress of the femoral vein in morbid obesity. Obes Surg. 2014;24: 806–812.
Bergan JJ, Schmid-Schonbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med. 2006;355:488-98.
Criqui MH, Jamosmos M, Fronek A, et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol. 2003;158:448-56.
Belczak CE, de Godoy JM, Belzack SQ, et al. Obesity and worsening of chronic venous disease and joint mobility. Phlebology. 2014, Vol. 29(8) 500–504.
Hirt PA, Castillo DE, Yosipovitch G, et al. Skin changes in the obese patient. J Am Acad Dermatol. 2019 Nov;81(5):1037-1057.
Lane RJ, Cuzzilla ML, Harris RA, et al. Popliteal vein compression syndrome: obesity, venous disease and the popliteal connection. Phlebology. 2009; 24: 201–207.
Padberg FT Jr, Maniker AH, Carmel G, et al. Sensory impairment: a feature of chronic venous insufficiency. J Vasc Surg. 1999:30:36-43.
Doerler M, Altmeyer P, Stücker M. Venous leg ulcer caused by Obesity-Associated Dependency Syndrome Case Report and Discussion of the Pathogenesis and Treatment. Phlebologie. 2013; 42: 205–208.
Mi Y,Yan S, LuY, et al.Venous thromboembolismhas the same risk factors as atherosclerosis: a PRISMA-compliant systemic review and meta-analysis. Medicine (Baltimore). 2016;95(32):e4495.
Kaye SM, Pietilainen KH, Kotronen A, et al. Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs. Obesity (Silver Spring) 2012; 20: 88–94.
Schmidt M, Johannesdottir SA, Lemeshow S, et al. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open. 2013;3(4). pii: e002698.
Heit JA, Rooke TW, Silverstein MD, et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg. 2001;33:1022–7.
Vedantham S. Valvular dysfunction and venous obstruction in the postthrombotic syndrome. Thromb Res. 2009;123(Suppl 4):62-65.
Bradbury A, Evans CJ, Allan P, et al. The relationship between lower limb symptoms and superficial and deep venous reflux on duplex ultrasonography: the Edinburgh Vein Study. J Vasc Surg. 2000; 32: 921–931.
Carruthers TN, Farber A, Rybin D, et al. Interventions on the superficial venous system for chronic venous insufficiency by surgeons in the modern era: an analysis of ACS-NSQIP. Vasc Endovasc Surg. 2014; 48: 482–490.
Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox. Thromb Res. 2011;128(6):518-523.
Guanella R, Ducruet T, Johri M, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost. 2011;9(12):2397-2405.
Eklöf B, Rutherford RB, Bergan JJ, et al; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.
Bozkurt AK. Kronik venöz yetersizlik. In: Bozkurt AK, editör. Periferik arter ve ven hastalıkları ulusal tedavi kılavuzu. İstanbul: Bayçınar Tıbbi Yayıncılık; 2016. 142–68.
Rabe E, Guex JJ, Puskas A, et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105–15.
Tita-Nwa F, Bos A, Adjei A, et al. Correlates of D-dimer in older persons. Aging Clin Exp Res. 2010; 22: 20–23.
Garg K, Kemp JL, Wojcik D, et al. Thromboembolic disease: comparison of combined CT pulmonary angiography and venography with bilateral leg sonography in 70 patients. Am J Roentgenol. 2000; 175: 997–1001.
Trayes KP, Studdiford JS, Pickle S, et al. Edema: diagnosis and management. Am Fam Physician. 2013 Jul 15;88(2):102-10.
Wittens C, Davies AH, Bækgaard N, et al. Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015 Jun;49(6):678-737.
Nicolaides A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I. Int Angiol. 2018;37(3):181–254 (Epub 2018/06/07).
Narvaes BL. Endovenous laser ablation: obesity and delivered LEED. In: International congress of the union internationale de phlebologie European chapter meeting, International Union of Phlebology Congress Proceedings, 2011, pp.5–17.
Deol ZK, Lakhanpal S, Franzon G, et al. Effect of obesity on chronic venous insufficiency treatment outcomes. J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):617-628.e1. doi: 10.1016/j.jvsv.2020.04.006. Epub 2020 Apr 23.
Raftopoulos I, Ercole J, Udekwu AO, et al. Outcomes of Roux-en-Y gastric bypass stratified by a body mass index of 70 kg/m2: a comparative analysis of 825 procedures. J Gastrointest Surg. 2005; 9: 44–52; discussion 3.
Campbell B, Chinai N, Hollering P, et al. Factors influencing the choice of treatment modality for individual patients with varicose veins. Ann R Coll Surg Engl. 2017; 99: 624–630.
Varatharajan L, Thapar A, Lane T, et al. Pharmacological adjuncts for chronic venous ulcer healing: a systematic review. Phlebology. 2016;31(5):356–65.
Millan SM, Gan R, Townsend PE. Venous Ulcers: Diagnosis and Treatment. Am Fam Physician. 2019; 100(5):298-305.
O’Donnell TF Jr, Lau J. A systematic review of randomized controlled trials of wound dressings for chronic venous ulcer. J Vasc Surg. 2006; 44:1118-25.
Barwell JR, Davies CE, Deacon J, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet. 2004;363:1854-9.
Hanley MJ, Abernethy DR and Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet. 2010; 49: 71–87.
Routledge PA, Chapman PH, Davies DM, et al. Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol. 1979; 15: 319–322.
Hillis CM, Crowther MA. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thromb Haemost. 2015; 113: 1193–1202.
Fleck D, Albadawi H, Shamoun F, et al. Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations. Cardiovasc Diagn Ther. 2017 Dec; 7(Suppl 3): 228–237.